Showing results (141-150 of 313) with videos related to

Sort By:
Pageof 32
Diabetes Care|January 31, 2015
Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetesAndrew Lewin, Ralph A DeFronzo, Sanjay Patel, et al.
Diabetes|May 28, 2005
Dose-response effect of elevated plasma free fatty acid on insulin signalingRenata Belfort, Lawrence Mandarino, Sangeeta Kashyap, et al.
Diabetes Care|June 23, 2017
Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?Muhammad Abdul-Ghani, Ralph A DeFronzo, Stefano Del Prato, et al.
The Journal of Clinical Endocrinology and Metabolism|April 20, 2018
Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin ReleaseJosé de Jesús Garduno-Garcia, Amalia Gastaldelli, Ralph A DeFronzo, et al.
Diabetes|January 26, 2012
Distinct β-cell defects in impaired fasting glucose and impaired glucose toleranceMustafa Kanat, Andrea Mari, Luke Norton, et al.
Cardiovascular Diabetology|April 29, 2021
From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetesOfri Mosenzon, Stefano Del Prato, Meir Schechter, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patientsYoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda, et al.
Pageof 32